SPAC JATT III Acquisition prices $60 million IPO, targeting biotech and life sciences
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, raised $60 million by offering 6 million shares at $10. Unlike most SPACs, the company is not offering units with warrants or rights attached. JATT...read more


